EUVIMEDEUVIMED entdecken
Übersichtsarbeit

IVIG-mediated effector functions in autoimmune and inflammatory diseases

Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry

International Immunology · 30.12.2017 · 29 (11) · 491-498

DOI: 10.1093/intimm/dxx039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 20.07.2017. Verfasst von Caroline Galeotti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale Unité, France. Die Arbeit wurde bisher 251-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intravenous immunoglobulin (IVIG) is a pooled preparation of normal IgG obtained from several thousand healthy donors. It is widely used in the immunotherapy of a large number of autoimmune and inflammatory diseases. The mechanisms of action of IVIG are complex and, as discussed in this review, experimental and clinical data provide an indicator that the therapeutic benefit of IVIG therapy is due to several mutually non-exclusive mechanisms affecting soluble mediators as well as cellular components of the immune system. These mechanisms depend on Fc and/or F(ab′)2 fragments. A better understanding of the effector functions of IVIG should help in identification of biomarkers of responses to IVIG in autoimmune patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesHumansImmunoglobulins, IntravenousInflammation

Stichwörter der Autor:innen

B cellautoimmunitydendritic cellgranulocytesialylation

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Institut National de la Santé et de la Recherche Médicale Unité, France.
  • Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
  • Centre de Recherche des Cordeliers, Equipe -Immunopathologie et Immunointervention Thérapeutique, Paris, France.
  • Department of Pediatric Rheumatology, National Referral Centre of Auto-inflammatory Diseases, CHU de Bicêtre, France.
  • Université Paris Descartes, Sorbonne Paris Cité, France.

Förderung

  • CSL Behring

Zitieren

APA

Galeotti, C., Kaveri, S. V., & Bayry, J. (2017). IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology, 29(11), 491-498. https://doi.org/10.1093/intimm/dxx039

Vancouver

Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology. 2017;29(11):491-498. doi:10.1093/intimm/dxx039

BibTeX
@article{Galeotti2017,
  author = {Galeotti, Caroline and Kaveri, Srini V and Bayry, Jagadeesh},
  title = {IVIG-mediated effector functions in autoimmune and inflammatory diseases},
  journal = {International Immunology},
  year = {2017},
  volume = {29},
  number = {11},
  pages = {491--498},
  doi = {10.1093/intimm/dxx039}
}
Kostenlos starten →